A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Cabot Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 5,355 shares of CBT stock, worth $495,605. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,355
Previous 4,260 25.7%
Holding current value
$495,605
Previous $391,000 53.2%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$86.96 - $111.73 $95,221 - $122,344
1,095 Added 25.7%
5,355 $599,000
Q2 2024

Jul 26, 2024

SELL
$90.69 - $102.77 $29,655 - $33,605
-327 Reduced 7.13%
4,260 $391,000
Q1 2024

Apr 24, 2024

BUY
$71.14 - $92.2 $30,803 - $39,922
433 Added 10.42%
4,587 $423,000
Q4 2023

Feb 09, 2024

BUY
$65.66 - $86.28 $272,751 - $358,407
4,154 New
4,154 $347,000
Q1 2022

May 12, 2022

SELL
$54.25 - $74.51 $234,848 - $322,553
-4,329 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$50.96 - $59.68 $220,605 - $258,354
4,329 New
4,329 $243,000

Others Institutions Holding CBT

About CABOT CORP


  • Ticker CBT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 56,299,200
  • Market Cap $5.21B
  • Description
  • Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such...
More about CBT
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.